1. Home
  2. Stock quotes
  3. Keros Therapeutics
  4. Financial Ratios
  5. EV/EBITDA Ratio
Keros Therapeutics logo
Keros Therapeutics KROS
$ 61.86 3.19%
mail-toReport an Error

Quarterly report 2024-Q2
added 08-07-2024

report update icon

Keros Therapeutics EV/EBITDA Ratio 2011-2024 | KROS

Annual EV/EBITDA Ratio Keros Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-20.3 -21.4 - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-20.3 -21.4 -20.8